SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021543
Filing Date
2022-11-03
Accepted
2022-11-03 07:20:51
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kymr-20220930.htm   iXBRL 10-Q 3628794
2 EX-31.1 kymr-ex31_1.htm EX-31.1 22105
3 EX-31.2 kymr-ex31_2.htm EX-31.2 21896
4 EX-32.1 kymr-ex32_1.htm EX-32.1 12680
5 EX-32.2 kymr-ex32_2.htm EX-32.2 12470
  Complete submission text file 0000950170-22-021543.txt   11900851

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kymr-20220930_pre.xml EX-101.PRE 385439
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kymr-20220930_lab.xml EX-101.LAB 550912
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kymr-20220930.xsd EX-101.SCH 68413
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kymr-20220930_cal.xml EX-101.CAL 57496
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kymr-20220930_def.xml EX-101.DEF 243807
66 EXTRACTED XBRL INSTANCE DOCUMENT kymr-20220930_htm.xml XML 2438878
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39460 | Film No.: 221356208
SIC: 2836 Biological Products, (No Diagnostic Substances)